AED Prescription Flashcards

(38 cards)

1
Q

Typically NPs do not

A

prescribe AEDs for epilepsy and seizures in primary care
• Neurology initiated; primary care may monitor
• Potential use of BZDs in emergency situation
• Seizure free 0-12 months before allowed to drive*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some AEDs can be prescribed to treat

A

migraine headache
• Topiramate
• Valproic Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Some AEDs are prescribed to treat

A
Mental Health conditions
• Carbamazepine
• Valproate
• Lamotrigine
• Topiramate
• Gabapentin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacokinetic Factors

in the Elderly - AED

A

Absorption - little change
⬧ Distribution
• Decrease in lean body mass important for highly lipid-soluble drugs
• Fall in albumin leading to higher free fraction
⬧ Metabolism - decreased hepatic enzyme content and blood flow
⬧ Excretion - decreased renal clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetic Factors

in Pediatrics - AED

A
⬧ Neonate - often lower per kg doses
• Low protein binding
• Low metabolic rate
⬧ Children - higher, more frequent doses
• Faster metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacokinetics in Pregnancy - AED

A
⬧ Increased volume of distribution
⬧ Lower serum albumin
⬧ Faster metabolism
⬧ Higher dose, but probably less than predicted by total level
(measure free level)
⬧ Consider more frequent dosing
⬧ Return to pre-pregnancy conditions rapidly (within 2 weeks)
after delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Be aware that drug interactions may occur when there is the:

A
  • addition of a new medication when an inducer/inhibitor is present.
  • addition of inducer/inhibitor to an existing medication regimen.
  • removal of an inducer/inhibitor from chronic medication regimen.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AEDs and Drug Interactions

A
⬧ Although many AEDs can cause pharmacokinetic
interactions, several agents appear to be less
problematic.
⬧ AEDs that do not appear to be either inducers or
inhibitors of the CYP system include:
gabapentin
lamotrigine
pregabalin
tiagabine
levetiracetam
zonisamide
lacosamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

• Important note about oral contraceptives (OCPs):

A

• OCP efficacy is decreased by inducers, including: phenytoin, phenobarbital,
primidone, carbamazepine, and higher doses of topiramate and oxcarbazepine
• OCPs and pregnancy significantly decrease serum levels of lamotrigine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Serum concentrations are useful when optimizing

A

AED therapy,

assessing adherence,or teasing out drug-drug interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Serum concentations should be used to

A

They should be used to monitor pharmacodynamic and

pharmacokinetic interactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Serum concentrations should be done

A

⬧ Should be done when documenting a serum concentration when a
patient is well controlled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Serum concentrations are also useful when

A

Serum concentrations are also useful when documenting positive or
negative outcomes associated with AED therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Serum concentrations most often indvidual patients

A

Most often individual patients define their own “therapeutic range” for
AEDs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Serum concentrations for the newAED there is no clearly

A

For the new AEDs there is no clearly defined “therapeutic range”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metabolic Changes of AEDs - Febrile

A
  • ↑ metabolic rate and ↓ serum concentrations

* ↑ serum proteins that can bind AEDs and ↓ free levels of AED serum concentrations

17
Q

Metabolic Changes of AEDs - Severe hepatic disease

A
  • Impairs metabolism and ↑ serum levels of AEDs
  • ↓ serum proteins and ↑ free levels of AED serum concentrations
  • Often serum levels can be harder to predict in this situation
18
Q

Metabolic Changes of AEDs - Renal

A
  • ↓ the elimination of some AEDs

* gabapentin, pregabalin, levetiracetam

19
Q

Metabolic Changes of AEDs - Chronic Renal

A
  • ↑ protein loss and ↑ free fraction of highly protein bound AEDs
  • It may be helpful to give smaller doses more frequently to ↓ adverse effects
  • phenytoin, valproic acid, tiagabine, vigabatrin
20
Q

Metabolic Changes of AEDs - Hemodialysis

A

⬧ Serum concentrations pre/post dialysis can be beneficial in this patient population
⬧ Bolus dosing of AEDs is sometimes recommended in this situation

21
Q

Sedation, fatigue -

A

All AEDs, except unusual with LTG and FBM

− More pronounced with traditional AED

22
Q

Unsteadiness, incoordination, dizziness

A

− Mainly traditional AEDs

− May be sign of toxicity with many AEDs

23
Q

Tremor

A

VALPORIC ACID

24
Q

Paresthesia

A

(topiramate, zonisamide)

25
Diplopia, blurred vision, visual distortion
(carbamazepine, lamotrigine)
26
Mental/motor slowing or impairment
(topiramate)
27
Mood or behavioral changes
(levetiracetam)
28
Changes in libido or sexual function
(carbamazepine, | phenytoin, phenobarbital)
29
Mild to moderate laboratory changes
* Hyponatremia: carbamazepine, oxcarbazepine * Increases in ALT or AST * Leukopenia * Thrombocytopenia
30
Weight gain/appetite changes
* valproic acid * gabapentin * pregabalin * vigabatrin
31
Weight loss
* topiramate * zonisamide * Felbamate
32
Hematologic damage
``` Marrow aplasia, agranulocytosis Early symptoms: abnormal bleeding, acute onset of fever, symptoms of anemia Laboratory monitoring probably not helpful in early detection Felbamate aplastic anemia approx. 1:5,000 treated patients Patient education ```
33
Endocrine/Metabolic Effects
``` Osteomalacia, osteoporosis (Vit D deficiency or other) • carbamazepine • barbiturates • phenytoin • oxcarbazepine • valproate ```
34
Teratogenesis (folate deficiency or other)
* barbiturates * phenytoin * carbamazepine * valproate (neural tube defects) * topiramate (cleft lip/cleft palate
35
Altered connective tissue metabolism or growth (facial | coarsening, hirsutism, gingival hyperplasia or contractures)
* phenytoin | * phenobarbital
36
Neurologic
* Neuropathy * phenytoin * carbamazepine * Cerebellar degeneration * phenytoin
37
``` Sexual Dysfunction (polycystic ovaries et al.) ```
* phenytoin * carbamazepine * phenobarbital * primidone
38
AED Hypersensitivity Syndrome
⬧ Characterized by rash, systemic involvement ⬧ Arene oxide intermediates - aromatic ring ⬧ Lack of epoxide hydrolase ⬧ Cross-reactivity • phenytoin • carbamazepine • Phenobarbital • oxcarbazepine ⬧ Relative cross reactivity - lamotrigine